Help your patients calculate their individual co-pay in a few short steps with this convenient tool.
NovoLog® makes analog insulin accessible1
Broad formulary coverage to help reach more lives2,a,b
Comparable coverage with regular human insulinc
NovoLog® formulary status at top Commercial health care and Medicare Part D plans is comparable to regular human insulin.c
a Formulary data are provided by Fingertip Formulary® and are current as of January 2016. Because formularies do change and many health plans offer more than one formulary, please check directly with the health plan to confirm coverage for individual patients. ⓒ 2016 Fingertip Formulary. All rights reserved.
b Managed care plans only. Does not include Medicaid and Medicare Part D. Intended as a guide. Lower acquisition costs alone do not necessarily reflect a cost advantage in the outcome of the condition treated because there are other variables that affect relative costs. Formulary status is subject to change. Multiple products within the same therapeutic class may be considered preferred and on the same tier.
c Regular human insulin is not a generic. No generic insulins are available in the United States.
More units. Same co-pay
One box of NovoLog® FlexPen® provides 50% more insulin than a vial for the same co-pay on most Commercial health care and Medicare Part D plans
9 out of 10 physicians say it is important to minimize patients’ out-of-pocket costs when prescribing3